72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and Vasculitis : How Should We Treat This Patient in the Context of Biomarkers Loss With Tocilizumab Usage? How Often Do We Need to Screen Patients With LVV for Aortic Aneurysm?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and Vasculitis : How Should We Treat This Patient in the Context of Biomarkers Loss With Tocilizumab Usage? How Often Do We Need to Screen Patients With LVV for Aortic Aneurysm?

By Vanderbilt University Medical Center (VUMC) FEATURING Kevin Byram

0 views

October 19, 2020

Comments 0

Shared Voices in the CSU Community

Feat. S. Gawchik

An Efficacy and Safety Review for Patients With Severe Eosinophilic …

Feat. Y. Goldman

Management of Raynaud’s Phenomenon